• Home

Para los 20 trabajos seleccionados para presentación oral, el investigador tiene que enviar la grabación de su presentación en formato MP4 (duración máxima 8 minutos) la cual debe ser en inglés, entre el 20 y 25 de noviembre. Posterior a la presentación se contará con 4 minutos de preguntas y comentarios. El archivo debe estar identificado con el número de presentación oral (PO), Enviar video al correo: [email protected]

Para la grabación se sugiere hacerlo en una sesión de zoom, compartir la pantalla, grabarse. El formato con que se guarda el archivo es MP4

Listado de presentaciones orales (PO) que serán evaluadas durante el congreso 2020
December 1 (Tuesday)
11:00 - 11:12 PO1 Differential methylation pattern in pubertal girls associated to biochemical premature adrenarche.
11:12 – 11:24 PO2 Effect of chemotherapy on endocrine testicular function during childhood and puberty in patients with acute lymphoblastic leukaemia or non-Hodgkin lymphoma: a prospective, longitudinal study.
11:24 – 11:36 PO3 Cortisol-binding globulin measurement is not useful as a complementary diagnostic test for adrenal insufficiency in a pediatric population.
11:36 – 11:48 PO4 Next-generation sequencing in the diagnosis of hypogonadotrophic hypogonadism and potential oligogenic mechanisms: difficulties for establishing the definitive aetiology
11:48 – 12:00 PO5 Neonatal hyperthyrotropinemia: looking at the end of the congenital hypothyroidism spectrum
December 2 (Wednesday)
11:00 - 11:12 PO6 Long-term vs. short-term obesity and its relation with cardiometabolic-risk in adolescence: exploring the role of sarcopenia in obesity
11:12 – 11:24 PO7 The usefulness of reverse T3 and reverse T3/T3 ratio to differentiate non-thyroidal illness from central hypothyroidism in children.
11:24 – 11:36 PO8 BMI throughout the life-course and its relation with bone-mass gain from adolescence to early adulthood: results from the Santiago Longitudinal Study
11:36 – 11: 48 PO9 Endocrine findings in Noonan Syndrome. Growth, molecular genetics, and growth hormone treatment (rhGHT)
11:48 – 12:00 PO10 Potentially pathogenic variants identified by next-generation sequencing in patients with short stature of unknown origin
December 3 (Thursday)
11:00 - 11:12 PO11 NGS implementation in a paediatric public hospital for the diagnosis of genetic endocrine disorders: preliminary results using clinical exome
11:12 – 11:24 PO12 Real risks of the insulin tolerance test (ITT) in diagnosis of growth hormone deficiency (GHD): almost ten years of experience.
11:24 – 11:36 PO13 Phenotype in Mexican children with osteogenesis imperfecta.
11:36 – 11:48 PO14 User-centered design of a connected health app for children with growth disorders in a real-world setting
11:48 – 12:00 PO15 Sensitivity and specificity of the auxological criteria (AC) for the diagnosis of growth hormone deficiency (GHD).
December 4 (Friday)
11:00 - 11:12 PO16 Clinical and analytical accuracy of continuous glucose monitoring and its utility in the management of a patient with congenital hyperinsulinism.
11:12 – 11:24 PO17 Congenital hyperinsulinism (CHI) due to a novel glucokinase-activating mutation.
11:24 – 11:36 PO18 Thyroid Autoimmunity and its Association with Karyotype in an Argentinian Cohort of Turner Syndrome Patients
11:36 – 11:48 PO19 Beta-cell functioning profile in obese pediatric population according to obesity severity and pubertal status
11:48 – 12:00 PO20 Efficacy and security of intensive management with insulin pump and continuous glucose monitoring in glycemic and metabolic control in a pediatric population with type 1 diabetes in a public hospital in Mexico during covid-19 pandemic.

1. El poster debe estar en inglés. El poster debe ser elaborado en Power point con la siguiente configuración: horizontal, Ancho 67cm y Largo 38cm. Una vez terminado, guardar en PDF y subir poster a la plataforma.

2. Los posters NO serán presentados. TODOS los congresistas tendrán acceso a éstos durante todo el congreso. Las medidas recomendadas son para que cuando accedan a un cartel puedan verlo de mejor forma en la pantalla de su computadora.

3. Para subir el poster, entrar a su perfil, junto al dictamen de su trabajo, cliquear en Subir Poster, a partir del día 18 y hasta el día 25 de noviembre.

AA1 Superiority of zoledronate to improve mineral density in children with osteogenesis imperfecta.
AA2 Bone mineral density as a face value: the role in body size dissatisfaction.
AA3 Poorly differentiated thyroid carcinoma, a rare case report in pediatrics
AA4 Development and validation of an educative manual for adolescents with type 2 diabetes.
AA5 Patients with Turners Syndrome treated with biosynthetic somatropin in a high specialty medical unit. experience from 1991 to 2019
AA6 Prevalence of thyroid disorders in patients with type 1 Diabetes Mellitus
AA7 Clinicopathological characteristics of thyroid cancer in pediatric patients attended in a High Specialty Medical Unit
AA8 Prevalence of type 2 Diabetes Mellitus in children and adolescents at a pediatric Hospital in México City, 2013-2018
AA9 Pseudohypoaldosteronism Type I: A Case Report
AA10 Evaluation of sexual orientation in patients with congenital adrenal hyperplasia (CAH) karyotype 46, XX.
AA11 Evaluation of the IMIEM protocol in the management of diabetic ketoacidosis
AA12 Sars-cov2 infection in pediatric patients with Diabetes Mellitus at the children’s Hospital of México Federico Gómez
AA13 Basal Insulin Dose Is Associated With Better Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
AA14 Introduction to a Multinational, Long-term, Prospective Outcomes Disease Monitoring Program (DMP) in Patients With X-linked Hypophosphatemia (XLH)
AA15 Persistent pelvic paraganglioma in a male adolescent
AA16 Central Diabetes Insipidus associated with Septo-optic Dysplasia-PLUS Syndrome in a newborn
AA17 Dipeptidyl peptidase-4 inhibitors combined with vitamin D3: An attempt to avoid the clinical phase of DM1. Clinical Case.
AA18 A positive newborn screen for 21 α-hydroxylase deficiency in a patient with 3β-Hydroxysteroid Dehydrogenase type 2 deficiency
AA19 Growth hormone effects on lipid metabolism in a non-alcoholic fatty liver disease in vitro model in HepG2 cells
AA21 Non-Thyroidal Illness in SARS-CoV-2 infection
AA22 Development of a behavior change training module for patient support nurse interventions to improve adherence in patients receiving treatment for growth hormone deficiencies.
AA23 Diffuse sclerosing variant of papillary thyroid carcinoma (DSPTC) in a pediatric cohort: prevalence, clinicopathological presentation, treatment and follow-up.
AA24 Pancreatic Insulinoma as etiology of seizures: Report of two cases
AA25 Case report: Ataxia Telangiectasia and Thyroid Carcinoma: an infrequent association in two sisters
AA26 Vitamin D Deficiency in SARS-CoV-2 infection
AA27 Chorea associated with hyperthyroidism in a pediatric patient
AA28 Subacute Thyroiditis, complication of SARS-CoV-2 infection
AA29 BMI and kidney function correlation in gradescholars and teenagers with overweight and obesity.
AA30 Juvenile granulosa cell tumor of the ovary (JGCT): A rare cause of peripheral precocious puberty (PPP)
AA31 Turner Syndrome: Identification of variations in the chromosomal constitution and its consequences on the clinical expression in a large number of patients
AA32 Percentage of body fat assessment using plicometry and bioelectrical impedance analysis in mexican children and adolescents with type 1 diabetes mellitus (T1DM)
AA33 Temporal series of hospitalizations and deaths due to congenital adrenal hyperplasia before and after the implementation of neonatal screening in Brazil
AA34 Menarche in a 9-month infant
AA35 The Role of Hyperinsulinemia in Slipped Capital Femoral Epiphysis
AA36 Acute suppurative thyroiditis (AST): experience in a pediatric endocrinology center
AA37 Adenoma tóxico en paciente preescolar
AA38 Vitamin D deficiency: prevalence and pulmonary implications in Mexican children with cystic fibrosis.
AA39 Clinical characteristics and management ot thyroid cancer in pediatrics: results from a National Mexican Registry
AA40 Thyroid carcinoma in a girl: advanced presentation with a rare histopathology in this pediatric population
AA41 Adrenal crisis due to XP21
AA42 Childhood adrenocortical carcinoma: Case report
AA43 Neuroendocrine Tumor of the Appendix in a Pediatric Patient: Case Report
AA44 Genetic characterization of patients with congenital adrenal hyperplasia
AA45 Central Precocious Puberty in a boy with Down syndrome and Ataxia Telangiectasia: a rare association
AA46 Cushings disease due to pituitary macroadenomas
AA47 Clinical-epidemiological characteristics and the treatment of patients with Turner Sindrome 2012 - 2018
AA48 Correlation between rotavirus vaccine and type 1 diabetes mellitus in pediatrics. Systematic review with metanalysis
AA49 Frequency of subclinical diabetic neuropathy and its relationship with metabolic control in pediatric patients with type 1 diabetes mellitus.
AA50 Ophthalmological manifestations in pediatric population with hyperthyroidism
AA51 An adolescent girl with Cushing disease. Diagnosis, management and evolution: A Mexican case report.
AA52 Cardiometabolic risk factors in children with intrauterine growth restriction at birth in relation to maternal characteristics
AA53 Evolution of children with metabolic syndrome with conventional treatment
AA54 Malignant paraganglioma: Treatment with sunitinib and primary hypothyroidism as a probable adverse effect in a thirteen years old girl
AA55 Diagnosis Delay of Pediatric Type 1 Diabetes Mellitus.
AA56 Effect of oral supplementation of flavonoids from cocoa on carbohydrate and lipid metabolism in obese patients aged 10 to 16 years, from Mexico City: a double-blind randomized clinical trial. Pilot study.
AA57 Case report: thyroid storm as a presentation of graves disease
AA58 Frequency of hypothalamus-hypophysis-gonadal axis dysfunction secondary to radiotherapy in pediatric cancer survivors from 2014 to 2019
AA59 Frequency and clinical impact of glucose abnormalities in Mexican children with cystic fibrosis.
AA60 Presence of pancreatic islet cell autoantibodies in a group of children and adolescents with type 1 diabetes mellitus at a pediatric center in Argentina.
AA61 Schmidt syndrome in pediatrics: on the purpose of a case
AA62 Psychomotor delay and short stature as a presentation of the Wiedemann-Steiner syndrome, pathogenic variant KMT2A:c.3569 1G>C. A Case report and literature review
AA63 Description of Growth in Pediatric Patients with Scald Burns
AA64 Quality of life and its correlation with Motor Functionality, Number of Fractures and Classification of Osteogenesis Imperfecta in Children
AA65 Transient neonatal diabetes: on the purpose of a case
AA66 Anemia due to iron deficiency and relationship with glycosylated hemoglobin levels in diabetic children
AA67 Transient Neonatal Hyperthyroidism: Report of 4 cases.
AA68 Intensive management with insulin pump and continuous glucose monitoring in patients with type 1 diabetes: impact in quality of life scores
AA69 Clinical, histopathological and genetic characteristics in a 46 XX testicular disorder of sexual development patient
AA70 Reporte de caso: pseudohipoparatiroidismo por deleción 20q13.2 – q13.33 en un paciente colombiano.
AA71 Burosumab therapy: case report of a 5-year-old girl with X-Linked Hypophosphatemic Rickets

Al terminar el Congreso, el autor responsable podrá obtener en la página web, el certificado online del trabajo presentado. El autor deberá pasarlo a los demás autores. Será emitido 01 (un) certificado por trabajo presentado

Importante: los certificados no serán enviados al email del congresista


Durante la Ceremonia de clausura se darán a conocer los trabajos ganadores

Premio Hormone Research in Paediatrics: mejor trabajo oral

Premio SLEP Oral: segundo mejor trabajo oral


No es necesario realizar el pago en el momento del registro del trabajo. El responsable del trabajo podrá efectuar el pago de inscripción hasta el día 16/11/2020, después de la divulgación de los trabajos aprobados, pero deberá pagar la tarifa vigente en la tabla de inscripción